Fischer Medical Ventures Ltd has informed the exchange on the recommendation of Dividend
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd's board, which met on May 28, 2025, approved the audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2025, with an unmodified audit opinion. The board recommended a final dividend of just Rs. 0.05 per equity share for FY25, payable within 30 days of the AGM if approved by shareholders. The board also approved the re-appointment of Bilimoria Mehta & Co. as statutory auditors for a second 5-year term, appointed S. Ramanand Aiyer & Co. as internal auditors for FY26, and recommended listing the company on the NSE Main Board.
The Rs. 0.05 per share dividend is a token payout and unlikely to be meaningful for income-focused investors; the bigger long-term story is the move toward NSE listing, which could improve liquidity and visibility. Shareholders should watch for the AGM date and any potential price reaction once NSE listing timelines are announced.